<VariationArchive RecordType="classified" VariationID="1621" VariationName="NM_000018.4(ACADVL):c.1080_1182+2del" VariationType="Deletion" Accession="VCV000001621" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2017-01-06" MostRecentSubmission="2017-01-06">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="16660" VariationID="1621">
      <GeneList>
        <Gene Symbol="ACADVL" FullName="acyl-CoA dehydrogenase very long chain" GeneID="37" HGNC_ID="HGNC:92" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>17p13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="7217125" stop="7225266" display_start="7217125" display_stop="7225266" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="7120443" stop="7128585" display_start="7120443" display_stop="7128585" Strand="+" />
          </Location>
          <OMIM>609575</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000018.4(ACADVL):c.1080_1182+2del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17p13</CytogeneticLocation>
      </Location>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008391.2" sequenceAccession="NG_008391" sequenceVersion="2" change="g.1816_1920del">
            <Expression>NG_008391.2:g.1816_1920del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001270447.2" sequenceAccession="NM_001270447" sequenceVersion="2" change="c.1149_1251+2del">
            <Expression>NM_001270447.2:c.1149_1251+2del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001270448.2" sequenceAccession="NM_001270448" sequenceVersion="2" change="c.852_954+2del">
            <Expression>NM_001270448.2:c.852_954+2del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000018.4" sequenceAccession="NM_000018" sequenceVersion="4" change="c.1080_1182+2del" MANESelect="true">
            <Expression>NM_000018.4:c.1080_1182+2del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001033859.3" sequenceAccession="NM_001033859" sequenceVersion="3" change="c.1014_1116+2del">
            <Expression>NM_001033859.3:c.1014_1116+2del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.7126454_7126558del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.7126454_7126558del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.7223135_7223239del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.7223135_7223239del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007975.1" sequenceAccession="NG_007975" sequenceVersion="1" change="g.8302_8406del">
            <Expression>NG_007975.1:g.8302_8406del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000018.4" sequenceAccession="NM_000018" sequenceVersion="4" change="c.1078_1182del" MANESelect="true">
            <Expression>NM_000018.4:c.1078_1182del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="609575.0001" DB="OMIM" />
        <XRef Type="rs" ID="2142981921" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="GenomicLocationNotEstablished">The genomic location for this variant will not be computed from alignment of the transcript sequence to the genome until there is experimental evidence for the genomic basis of the loss of exon 11 (	NM_000018.4).</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000018.4(ACADVL):c.1080_1182+2del AND Very long chain acyl-CoA dehydrogenase deficiency" Accession="RCV000001688" Version="3">
        <ClassifiedConditionList TraitSetID="417">
          <ClassifiedCondition DB="MedGen" ID="C3887523">Very long chain acyl-CoA dehydrogenase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1995-08-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1995-08-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-01-06" MostRecentSubmission="2017-01-06">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">7668252</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="417" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="27" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Very long chain acyl-CoA dehydrogenase deficiency</ElementValue>
                <XRef ID="VLCAD+deficiency/7410" DB="Genetic Alliance" />
                <XRef ID="MONDO:0008723" DB="MONDO" />
                <XRef ID="237997005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">VLCAD deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ACADVLD</ElementValue>
                <XRef Type="MIM" ID="201475" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">VLCAD</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">VLCADD</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5508" />
                <XRef ID="5508" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Deficiency of very long-chain acyl-coenzyme A dehydrogenase (VLCAD), which catalyzes the initial step of mitochondrial beta-oxidation of long-chain fatty acids with a chain length of 14 to 20 carbons, is associated with three phenotypes. The severe early-onset cardiac and multiorgan failure form typically presents in the first months of life with hypertrophic or dilated cardiomyopathy, pericardial effusion, and arrhythmias, as well as hypotonia, hepatomegaly, and intermittent hypoglycemia. The hepatic or hypoketotic hypoglycemic form typically presents during early childhood with hypoketotic hypoglycemia and hepatomegaly, but without cardiomyopathy. The later-onset episodic myopathic form presents with intermittent rhabdomyolysis provoked by exercise, muscle cramps and/or pain, and/or exercise intolerance. Hypoglycemia typically is not present at the time of symptoms.</Attribute>
                <XRef ID="NBK6816" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301763</ID>
                <ID Source="BookShelf">NBK6816</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="GMDI/SERN, 2021">
                <URL>https://managementguidelines.net/guidelines.php/130/VLCAD%20Nutrition%20Guidelines/Version%201.1</URL>
                <CitationText>VLCAD Nutrition Management Guidelines</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C14.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C14:1 +/- other long-chain acylcarnitines, Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency, 2022</CitationText>
              </Citation>
              <XRef ID="26793" DB="Orphanet" />
              <XRef ID="C3887523" DB="MedGen" />
              <XRef ID="MONDO:0008723" DB="MONDO" />
              <XRef Type="MIM" ID="201475" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="21844" SubmissionDate="2016-12-08" DateLastUpdated="2017-01-06" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="609575.0001_VLCAD DEFICIENCY" title="ACADVL, 105-BP DEL_VLCAD DEFICIENCY" />
        <ClinVarAccession Accession="SCV000021844" DateUpdated="2017-01-06" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1995-08-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 patients with VLCAD deficiency (201475), Aoyama et al. (1995) identified a 105-bp deletion encompassing bases 1078-1182 in the VLCAD cDNA. The deletion was thought to result from exon skipping and was predicted to result in the in-frame deletion of 35 amino acids, beginning with val360 of the precursor VLCAD. Using the vaccinia viral system, Aoyama et al. (1995) performed quantitative cDNA expression of normal human VLCAD in the patients' fibroblasts and demonstrated that raising VLCAD activity to approximately 20% of normal control fibroblast activity raised palmitic acid beta-oxidation flux to the level found in control fibroblasts. The mutation described in these patients has consequences for enzyme folding and assembly that are similar to those for the well-characterized A985G mutation (lys329-to-glu; 607008.0001) found in approximately 90% of the mutant alleles in patients with MCAD deficiency (201450).</Attribute>
              <Citation>
                <ID Source="PubMed">7668252</ID>
              </Citation>
              <XRef DB="OMIM" ID="201475" Type="MIM" />
              <XRef DB="OMIM" ID="201450" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACADVL" />
          </GeneList>
          <Name>ACADVL, 105-BP DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">105-BP DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="609575.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">VLCAD DEFICIENCY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="21844" TraitType="Disease" MappingType="Name" MappingValue="VLCAD DEFICIENCY" MappingRef="Preferred">
        <MedGen CUI="C3887523" Name="Very long chain acyl-CoA dehydrogenase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

